Have a personal or library account? Click to login
Incidence, Predictors, and Outcomes of Acute and Subacute Stent Thrombosis after Emergency Percutaneous Coronary Revascularization with Drug-Eluting Stents: A Prospective Observational Study Cover

Incidence, Predictors, and Outcomes of Acute and Subacute Stent Thrombosis after Emergency Percutaneous Coronary Revascularization with Drug-Eluting Stents: A Prospective Observational Study

Global Heart
Volume 17 (2022): Issue 1
By: Rajesh Kumar,  Ali Ammar,  Tahir Saghir,  Jawaid Akbar Sial,  Jehangir Ali Shah,  Ashok Kumar,  Abdul Hakeem Shaikh,  Abdul Samad Achakzai,  Nadeem Qamar and  Musa Karim  
Open Access
|Mar 2022

References

  1. 1Katsikis A, Keeble TR, Davies JR, et al. Contemporary management of stent thrombosis: Predictors of mortality and the role of new-generation drug-eluting stents. Catheterization and Cardiovascular Interventions. 2020; 96(1): E8–E16. DOI: 10.1002/ccd.28467
    Back to article
  2. 2Kuramitsu S, Sonoda S, Ando K, et al. Drug-eluting stent thrombosis: Current and future perspectives. Cardiovascular intervention and therapeutics. 2021; 36(2): 158–68. DOI: 10.1007/s12928-021-00754-x
    Back to article
  3. 3Kohsaka S. Identification of patient-related factors in stent thrombosis. Circulation Journal. 2020; 84(9): 1464–6. DOI: 10.1253/circj.CJ-20-0674
    Back to article
  4. 4Claessen BE, Henriques JP, Jaffer FA, Mehran R, Piek JJ, Dangas GD. Stent thrombosis: A clinical perspective. JACC: Cardiovascular Interventions. 2014; 7(10): 1081–92. DOI: 10.1016/j.jcin.2014.05.016
    Back to article
  5. 5Clemmensen P, Wiberg S, Van’t Hof A, et al. Acute stent thrombosis after primary percutaneous coronary intervention: insights from the EUROMAX trial (European Ambulance Acute Coronary Syndrome Angiography). JACC: Cardiovascular Interventions. 2015; 8(1 Part B): 214–20. DOI: 10.1016/j.jcin.2014.11.002
    Back to article
  6. 6Nakano M, Yahagi K, Otsuka F, et al. Causes of early stent thrombosis in patients presenting with acute coronary syndrome: An ex vivo human autopsy study. Journal of the American College of Cardiology. 2014; 63(23): 2510–20. DOI: 10.1016/j.jacc.2014.02.607
    Back to article
  7. 7Van Werkum JW, Heestermans AA, Zomer AC, et al. Predictors of coronary stent thrombosis: the Dutch Stent Thrombosis Registry. Journal of the American College of Cardiology. 2009; 53(16): 1399–409. DOI: 10.1016/j.jacc.2008.12.055
    Back to article
  8. 8Stone GW, Witzenbichler B, Guagliumi G, et al. Heparin plus a glycoprotein IIb/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): Final 3-year results from a multicentre, randomised controlled trial. The Lancet. 2011; 377(9784): 2193–204. DOI: 10.1016/S0140-6736(11)60764-2
    Back to article
  9. 9Levine GN, Bates ER, Bittl JA, et al. 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Journal of the American College of Cardiology. 2016; 68(10): 1082–115. DOI: 10.1016/j.jacc.2016.03.513
    Back to article
  10. 10Thygesen K, Alpert JS, Jaffe AS, et al. Fourth universal definition of myocardial infarction (2018). European heart journal. 2019; 40(3): 237–69. DOI: 10.1093/eurheartj/ehy462
    Back to article
  11. 11Cutlip DE, Windecker S, Mehran R, et al. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation. 2007; 115(17): 2344–51. DOI: 10.1161/CIRCULATIONAHA.106.685313
    Back to article
  12. 12Tariq S, Kumar R, Fatima M, Saghir T, Masood S, Karim M. Acute and sub-acute stent thrombosis: Frequency, predictors and features in patients undergoing primary percutaneous intervention at a tertiary care cardiac centre. IJC Heart & Vasculature. 2020; 26(2020): 100427. DOI: 10.1016/j.ijcha.2019.100427
    Back to article
  13. 13Lim S, Koh Y-S, Kim P-J, et al. Incidence, implications, and predictors of stent thrombosis in acute myocardial infarction. The American Journal of Cardiology. 2016; 117(10): 1562–8. DOI: 10.1016/j.amjcard.2016.02.029
    Back to article
  14. 14de la Torre-Hernández JM, Alfonso F, Hernández F, et al. Drug-eluting stent thrombosis: Results from the multicenter Spanish registry ESTROFA (Estudio ESpanol sobre TROmbosis de stents FArmacoactivos). Journal of the American College of Cardiology. 2008; 51(10): 986–90. DOI: 10.1016/j.jacc.2007.10.057
    Back to article
  15. 15Brodie B, Pokharel Y, Garg A, et al. Predictors of early, late, and very late stent thrombosis after primary percutaneous coronary intervention with bare-metal and drug-eluting stents for ST-segment elevation myocardial infarction. JACC: Cardiovascular Interventions. 2012; 5(10): 1043–51. DOI: 10.1016/j.jcin.2012.06.013
    Back to article
  16. 16Koskinas KC, Taniwaki M, Rigamonti F, et al. Impact of patient and lesion complexity on long-term outcomes following coronary revascularization with new-generation drug-eluting stents. The American Journal of Cardiology. 2017; 119(4): 501–7. DOI: 10.1016/j.amjcard.2016.10.038
    Back to article
  17. 17Park KW, Hwang S-J, Kwon D-A, et al. Characteristics and predictors of drug-eluting stent thrombosis–Results From the MulticenterKorea Stent Thrombosis (KoST)’ Registry. Circulation Journal. 2011; 75(7): 1626–32. DOI: 10.1253/circj.CJ-10-1160
    Back to article
  18. 18Rozemeijer R, Wong CW, Leenders G, et al. Incidence, angiographic and clinical predictors, and impact of stent thrombosis: A 6-year survey of 6,545 consecutive patients. Netherlands Heart Journal. 2019; 27(6): 321–9. DOI: 10.1007/s12471-019-1253-2
    Back to article
  19. 19Wijns W, Shite J, Jones MR, et al. Optical coherence tomography imaging during percutaneous coronary intervention impacts physician decision-making: ILUMIEN I study. European Heart Journal. 2015; 36(47): 3346–55. DOI: 10.1093/eurheartj/ehv367
    Back to article
  20. 20Souteyrand G, Amabile N, Mangin L, et al. Mechanisms of stent thrombosis analysed by optical coherence tomography: Insights from the national PESTO French registry. European heart journal. 2016; 37(15): 1208–16. DOI: 10.1093/eurheartj/ehv711
    Back to article
  21. 21Prati F, Kodama T, Romagnoli E, et al. Suboptimal stent deployment is associated with subacute stent thrombosis: Optical coherence tomography insights from a multicenter matched study. From the CLI Foundation investigators: the CLI-THRO study. American Heart Journal. 2015; 169(2): 249–56. DOI: 10.1016/j.ahj.2014.11.012
    Back to article
  22. 22Ali ZA, Maehara A, Généreux P, et al. Optical coherence tomography compared with intravascular ultrasound and with angiography to guide coronary stent implantation (ILUMIEN III: OPTIMIZE PCI): A randomised controlled trial. The Lancet. 2016; 388(10060): 2618–28. DOI: 10.1016/S0140-6736(16)31922-5
    Back to article
  23. 23Wiviott SD, Braunwald E, Angiolillo DJ, et al. Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel–Thrombolysis in Myocardial Infarction 38. Circulation. 2008; 118(16): 1626–36. DOI: 10.1161/CIRCULATIONAHA.108.791061
    Back to article
  24. 24van Boven N, Windecker S, Umans VA, et al. Stent thrombosis in early-generation drug-eluting stents versus newer-generation everolimus-eluting stent assorted by LVEF. Heart. 2015; 101(1): 50–7. DOI: 10.1136/heartjnl-2014-305743
    Back to article
DOI: https://doi.org/10.5334/gh.1112 | Journal eISSN: 2211-8179
Journal RSS Feed
Language: English
Submitted on: Dec 16, 2021
Accepted on: Mar 9, 2022
Published on: Mar 30, 2022
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
STEMI,
primary PCI,
DES,
acute,
sub-acute,
stent thrombosis,
MACE

© 2022 Rajesh Kumar, Ali Ammar, Tahir Saghir, Jawaid Akbar Sial, Jehangir Ali Shah, Ashok Kumar, Abdul Hakeem Shaikh, Abdul Samad Achakzai, Nadeem Qamar, Musa Karim, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous articleVolume 17 (2022): Issue 1Next article